Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis

Redox Biology(2020)10.1016/j.redox.2020.101509Source: DataRank Database

Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis is a research paper published in Redox Biology (2020). On theSindex it has a DataRank of 0. It has been cited 269 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access269 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 11.26)OA: goldTopics (51)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Jazmín Calyeca,Mauricio Rojas ORCID,Ana L. Mora ORCID,Marta Bueno ORCID

Live enrichment

PubMed:32234292 PMC:PMC7251240 OpenAlex:https://openalex.org/W3012377026

National Institutes of Health

Grant: U01 HL145550-01

National Institutes of Health

Grant: R01 HL131789-03

National Institutes of Health

Grant: 5 R01 HL123766-04

National Institutes of Health

Grant: R01 HL149825

NHLBI NIH HHS

Grant: U01 HL145550

NHLBI NIH HHS

Grant: R01 HL123766

NHLBI NIH HHS

Grant: R01 HL131789

National Institutes of Health

Grant: 7U01HL145550-03

Mapping Age-Related Changes in the Lung

National Institutes of Health

Grant: 1R01HL149825-01

Type II Alveolar Redox Control in Fibrogenesis and Resolution

National Institutes of Health

Grant: 1R01HL123766-01A1

Aging of Mesenchymal Stem Cells Missing Link in IPF

National Institutes of Health

Grant: 5R01HL131789-04

Signaling mechanisms by which mitochondria regulates fibrosis in the lung

FWCI

11.26

Citation Percentile

1.0%

Citation Trend

2018

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S2213231720301786/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2213231720301786/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213231720301786?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213231720301786?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.redox.2020.101509

Fields of Study

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisAutophagy in Disease and TherapyChronic Obstructive Pulmonary Disease (COPD) Research0301 basic medicine0303 health sciences03 medical and health sciencesAgingFibroblastsHumansIdiopathic Pulmonary FibrosisLungMitochondria

MeSH Terms

AgingFibroblastsHumansLungMitochondriaIdiopathic Pulmonary Fibrosis

Keywords

Idiopathic pulmonary fibrosisPulmonary fibrosisFibrosisReprogrammingMitochondrionLungMitochondrial biogenesisExtracellular matrixBiologyMitophagyInterstitial lung diseaseImmunologyPathologyMedicineCancer researchCell biologyInternal medicineCellGeneticsApoptosisFibroblastAgingMacrophageEpithelial cellsMitochondrial DysfunctionMedicine (General)QH301-705.5FibroblastsArticleMitochondriaR5-920HumansBiology (General)

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Lung immune signatures define two groups of end-stage IPF patients

10.6084/m9.figshare.26620774.v1figshare

Additional file 1 of Lung immune signatures define two groups of end-stage IPF patients

10.6084/m9.figshare.26620774figshare

Additional file 1 of Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs

10.6084/m9.figshare.16935609.v1figshare

Additional file 1 of Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs

10.6084/m9.figshare.16935609figshare

Additional file 1 of PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo

10.6084/m9.figshare.23290409.v1figshare

Additional file 1 of PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo

10.6084/m9.figshare.23290409figshare

Additional file 5 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711348.v1figshare

Additional file 5 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711348figshare

Additional file 6 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711351.v1figshare

Additional file 6 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711351figshare

Additional file 2 of Lung immune signatures define two groups of end-stage IPF patients

10.6084/m9.figshare.26620777figshare

Additional file 2 of Lung immune signatures define two groups of end-stage IPF patients

10.6084/m9.figshare.26620777.v1figshare

Additional file 2 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711339.v1figshare

Additional file 3 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711342figshare

Additional file 3 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711342.v1figshare

Additional file 4 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711345.v1figshare

Additional file 4 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711345figshare

Additional file 2 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711339figshare

Additional file 1 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711336figshare

Additional file 1 of Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts

10.6084/m9.figshare.26711336.v1figshare

Related Papers (8)

Integrated analysis of multimodal single-cell data

N/A

1.4DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.04.048

Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis

N/A

1.1DataRank · unranked

Science Advances(2020)

co-cited

10.1126/sciadv.aba1983

NAD+/NADH redox alterations reconfigure metabolism and rejuvenate senescent human mesenchymal stem cells in vitro

N/A

2.0DataRank · unranked

Communications Biology(2020)

co-cited

10.1038/s42003-020-01514-y

Wnt/β-catenin signaling is critical for regenerative potential of distal lung epithelial progenitor cells in homeostasis and emphysema

Stem Cells(2020)

co-cited

10.1002/stem.3241

Adenine nucleotide translocase regulates airway epithelial metabolism, surface hydration and ciliary function

N/A

0.515DataRank · unranked

Journal of Cell Science(2021)

co-cited

10.1242/jcs.257162

Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis

N/A

1.0DataRank · unranked

eLife(2023)

co-cited

10.7554/elife.85415

Telomere-mediated lung disease

N/A

0.724DataRank · unranked

Physiological Reviews(2022)

co-cited

10.1152/physrev.00046.2021

The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression

N/A

11.5DataRank · unranked

Annual Review of Pathology: Mechanisms of Disease(2010)

co-cited

10.1146/annurev-pathol-121808-102144

Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis

FAIR Checklist

Authors (4)

Funding (11 grants)

Impact

Open Access

Topics

Linked Datasets (20)

Annotations (Europe PMC)

Related Papers (8)